Our survey with the ACC CO and ACPC groups is a step toward understanding how practitioners are managing #pediatric #anthracyline #cardiotoxicity. @ACCinTouch @ACCinTouch @AnaBaracCardio https://t.co/SceFHkAj8F
RT @BrJCardiol: A 20-question survey (65 doctors) from @ACCinTouch Pediatric Cardio-oncology Work Group shows most US centres regularly scr…
RT @BrJCardiol: A 20-question survey (65 doctors) from @ACCinTouch Pediatric Cardio-oncology Work Group shows most US centres regularly scr…
RT @arjunkg: I suspect would be similar in UK centres @GOSHCharity @TheChristieSoO @uclh https://t.co/LNFwpQNLAJ
I suspect would be similar in UK centres @GOSHCharity @TheChristieSoO @uclh
RT @BrJCardiol: A 20-question survey (65 doctors) from @ACCinTouch Pediatric Cardio-oncology Work Group shows most US centres regularly scr…
A 20-question survey (65 doctors) from @ACCinTouch Pediatric Cardio-oncology Work Group shows most US centres regularly screened (ECG 75%, echo 58%) @BSEcho childhood cancer patients prior to and during cancer therapy. https://t.co/0EnpXyzTIz @BCOSCardioO
RT @EuroCardioOnc: Dr Ana Barac (@AnaBaracCardio) & the ACC Paediatric #CardioOnc Work Group evaluated cardiovascular care in paediatric ca…
RT @EuroCardioOnc: Dr Ana Barac (@AnaBaracCardio) & the ACC Paediatric #CardioOnc Work Group evaluated cardiovascular care in paediatric ca…
RT @EuroCardioOnc: Dr Ana Barac (@AnaBaracCardio) & the ACC Paediatric #CardioOnc Work Group evaluated cardiovascular care in paediatric ca…
RT @EuroCardioOnc: Dr Ana Barac (@AnaBaracCardio) & the ACC Paediatric #CardioOnc Work Group evaluated cardiovascular care in paediatric ca…
RT @EuroCardioOnc: Dr Ana Barac (@AnaBaracCardio) & the ACC Paediatric #CardioOnc Work Group evaluated cardiovascular care in paediatric ca…
RT @EuroCardioOnc: Dr Ana Barac (@AnaBaracCardio) & the ACC Paediatric #CardioOnc Work Group evaluated cardiovascular care in paediatric ca…
Dr Ana Barac (@AnaBaracCardio) & the ACC Paediatric #CardioOnc Work Group evaluated cardiovascular care in paediatric cancer patients & survivors: https://t.co/060ZwLOiWG At #ECOS19 we asked: should all patients be monitored for lifelong late effec